March 21 (Reuters) -
* FDA: ABIOMED RECALLS THE INSTRUCTIONS FOR USE FOR IMPELLA LEFT SIDED BLOOD PUMPS DUE TO PERFORATION RISKS
* FDA: HAS IDENTIFIED ABIOMED'S RECALL OF INSTRUCTIONS FOR USE FOR IMPELLA LEFT SIDED BLOOD PUMPS AS A CLASS I RECALL
* FDA: THERE HAVE BEEN 129 REPORTED SERIOUS INJURIES, INCLUDING 49 REPORTS OF DEATH RELATED TO THIS ABIOMED RECALL
Source text for Eikon: Further company coverage: [ ]
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments